URGN

UroGen Pharma
URGN

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$621.99M
EV
$547.95M
Shares Outstanding
46.11M
Beta
0.93

Wall Street View

Analyst Rating
BUY
Analyst Target Price
$34.38
P/E 2025E
-
P/Revenue 2025E
5.02x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About UroGen Pharma Ltd.

gainify
URGN

UroGen Pharma Ltd.

URGN

UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization of solutions for urothelial and specialty cancers. It offers RTGel, a novel proprietary polymeric biocompatible, reverse thermal gelation hydrogel technology to improve thera...

Sector

Healthcare

Industry

Biotechnology

CEO

Barrett, Elizabeth

Employees

234

IPO Date

2017-05-04

Headquarters

400 Alexander Park Drive, 4th Floor, Princeton, New Jersey, 08540, United States

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

COMPANY

Pricing

Dashboard

About Us

Contact Us

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.